Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, offering promising developments across many clinical and industrial applications. With its structural similarity to Obviously derived human serum albumin, OsrHSA gives a safer, a lot more trusted alternate for therapeutic use, parti